Antimicrobial activity and ADMET analysis of novel coumarin-based pyridine and pyran hybrids
Abstract
A series of novel pyridine and pyran incorporated chromene moiety have been synthesized using 6-(2-(4-nitrophenyl) diazenyl)-3-acetyl-2 H-chromen-2-one 1 as the starting material. The chemical structures of the newly synthesized derivatives were characterized using different spectroscopic techniques (FT-IR, ¹ HNMR and ¹³ CNMR) and elemental analysis. All derivatives were assessed for their in vitro antimicrobial activity against six clinically isolated multi-drug resistance strains, including Gram-positive ( Bacillus pumilis , Streptococcus faecalis ) and Gram-negative ( Escherichia coli , Enterobacter cloacae ) bacteria and fungi ( Saccharomyces cerevisiae , Candida albicans ) using broth microdilution and agar well-diffusion technique assays. The synthesized compounds exhibited moderate to good antimicrobial activity against the tested strains, with several derivatives approaching, and in one instance matching, the potency of the reference drugs. Notably, 2a , 5a , 5b , 6b , 7b , and 8a derivatives merged as the most promising bactericidal and fungicidal agents Compound 5a demonstrated an excellent activity toward S. faecalis which is equal to Penicillin G. with MIC value (3.91 µg/ml) and MBC value (31.3 µg/ml). Furthermore, compounds 5b , 6b , 7b and 8a revealed an excellent potency against S. faecalis with MIC value (7.81 µg/ml) and bactericidal activity with MBC value from 15.6 to 62.5 µg/ml Furthermore, in-silico ADMET analysis of compounds 6a , 6b , 8a , and 8b demonstrated adherence to Pfizer’s guidelines, reflecting favorable physicochemical properties.
Related
- In silico DFT, ADMET and molecular docking studies of novel coumarin-linked pyrazole and quinoline derivatives as antimicrobial and antioxidant agents
- Pyridine-3-Carboxamide–1,3,4-Thiadiazole Hybrids as Antimicrobial Agents: Synthesis, Biological Evaluation, In Vivo Toxicity, and Computational Studies
- Biofabricated Al₂O₃ nanoparticles as a recyclable heterogeneous catalyst for nicotinonitrile synthesis: antimicrobial activity, molecular docking and ADMET assessment.
- Chalcone-pyridine/pyrimidine hybrids: promising candidates for anticancer drug development
- Rational design and synthesis of furan-based Schiff base quinazolin-4-amine hybrids: spectral elucidation, molecular docking, DFT studies, and in silico ADMET-antioxidant study.
BibTeX
@article{ahmed2026antimicrobial,
title = {{Antimicrobial activity and ADMET analysis of novel coumarin-based pyridine and pyran hybrids}},
author = {Ghada E. Ahmed and Sadia A. Hessein and Asmaa Abd El haleem and Nadia A. M. Shmiess and Sawsan A. Fouad},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-72725-2},
url = {https://www.nature.com/articles/s41598-026-72725-2},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Antimicrobial activity and ADMET analysis of novel coumarin-based pyridine and pyran hybrids
AU - Ghada E. Ahmed
AU - Sadia A. Hessein
AU - Asmaa Abd El haleem
AU - Nadia A. M. Shmiess
AU - Sawsan A. Fouad
PY - 2026
DA - 2026/10/17
JO - Scientific Reports
DO - 10.1038/s41598-026-72725-2
UR - https://www.nature.com/articles/s41598-026-72725-2
AB - A series of novel pyridine and pyran incorporated chromene moiety have been synthesized using 6-(2-(4-nitrophenyl) diazenyl)-3-acetyl-2 H-chromen-2-one 1 as the starting material. The chemical structures of the newly synthesized derivatives were characterized using different spectroscopic techniques (FT-IR, ¹ HNMR and ¹³ CNMR) and elemental analysis. All derivatives were assessed for their in vitro antimicrobial activity against six clinically isolated multi-drug resistance strains, including Gram-positive ( Bacillus pumilis , Streptococcus faecalis ) and Gram-negative ( Escherichia coli , Enterobacter cloacae ) bacteria and fungi ( Saccharomyces cerevisiae , Candida albicans ) using broth microdilution and agar well-diffusion technique assays. The synthesized compounds exhibited moderate to good antimicrobial activity against the tested strains, with several derivatives approaching, and in one instance matching, the potency of the reference drugs. Notably, 2a , 5a , 5b , 6b , 7b , and 8a derivatives merged as the most promising bactericidal and fungicidal agents Compound 5a demonstrated an excellent activity toward S. faecalis which is equal to Penicillin G. with MIC value (3.91 µg/ml) and MBC value (31.3 µg/ml). Furthermore, compounds 5b , 6b , 7b and 8a revealed an excellent potency against S. faecalis with MIC value (7.81 µg/ml) and bactericidal activity with MBC value from 15.6 to 62.5 µg/ml Furthermore, in-silico ADMET analysis of compounds 6a , 6b , 8a , and 8b demonstrated adherence to Pfizer’s guidelines, reflecting favorable physicochemical properties.
SN - 2045-2322
ER -